Wednesday, March 03, 2021 1:51:51 PM
Gus McCrae,
Dr. Linda Liau is lamenting the pioneering aspect of the technology she developed. The company she is obviously pointing to as a disrupter is the one that asked a professor to develop a better manufacturing process which eventually became known as Flaskworks which NWBO bought with cash and stock. I’d say her vision of a company that changes the way manufacturing is done and the way trials to approval being done are being handily pioneered by NWBO, the only company willing to move her original research forward and the only company fitting the bill as a game changer with CRL as a partner for manufacturing. She wants this available to patients ASAP and laments the patent process, FDA and manufacturing issues that have held this process up substantially. She never spoke to the issue of financing which NWBO and other small bios almost always struggle with unles they give away the farm. Best wishes.
Dr. Linda Liau is lamenting the pioneering aspect of the technology she developed. The company she is obviously pointing to as a disrupter is the one that asked a professor to develop a better manufacturing process which eventually became known as Flaskworks which NWBO bought with cash and stock. I’d say her vision of a company that changes the way manufacturing is done and the way trials to approval being done are being handily pioneered by NWBO, the only company willing to move her original research forward and the only company fitting the bill as a game changer with CRL as a partner for manufacturing. She wants this available to patients ASAP and laments the patent process, FDA and manufacturing issues that have held this process up substantially. She never spoke to the issue of financing which NWBO and other small bios almost always struggle with unles they give away the farm. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
